1. Regulation of transforming growth factor-β signalling by SUMOylation and its role in fibrosis
    Xinyi Wang et al, 2021, Open Biology CrossRef
  2. The HECT ubiquitin E3 ligase Smurf2 degrades μ-opioid receptor 1 in the ubiquitin-proteasome system in lung epithelial cells
    Su Dong et al, 2019, American Journal of Physiology-Cell Physiology CrossRef
  3. Transcriptional cofactors Ski and SnoN are major regulators of the TGF-β/Smad signaling pathway in health and disease
    Angeles C. Tecalco-Cruz et al, 2018, Signal Transduction and Targeted Therapy CrossRef
  4. MicroRNA: A new generation therapeutic target in diabetic nephropathy
    Saikat Dewanjee et al, 2018, Biochemical Pharmacology CrossRef
  5. Combination therapy of tripterygium glycosides plus valsartan in diabetic nephropathy treatment: A systematic review and meta-analysis
    Wan-chun Ye et al, 2019, Chinese Herbal Medicines CrossRef
  6. The role of SMURFs in non‐cancerous diseases
    Dong Wang et al, 2023, The FASEB Journal CrossRef
  7. Smad2 and Smad3 play antagonistic roles in high glucose-induced renal tubular fibrosis via the regulation of SnoN
    Yuanyuan Wang et al, 2020, Experimental and Molecular Pathology CrossRef
  8. TAK1 may promote the development of diabetic nephropathy by reducing the stability of SnoN protein
    Yuanyuan Wang et al, 2019, Life Sciences CrossRef
  9. Platycodin D inhibits HFD/STZ-induced diabetic nephropathy via inflammatory and apoptotic signaling pathways in C57BL/6 mice
    Qiong Shen et al, 2023, Journal of Ethnopharmacology CrossRef
  10. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment
    Lin Chen et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  11. The effects of microRNA-126 reduced inflammation and apoptosis of diabetic nephropathy through PI3K/AKT signalling pathway by VEGF
    Zhe Lou et al, 2022, Archives of Physiology and Biochemistry CrossRef
  12. cMet agonistic antibody prevents acute kidney injury to chronic kidney disease transition by suppressing Smurf1 and activating Smad7
    Lilin Li et al, 2021, Clinical Science CrossRef